Trial intelligence / Profile preview

Pilocarpine After Combined Cataract/Kahook Dual Blade Surgery

NCT03933631Phase 3Recruiting

Sponsor
Montefiore Medical Center
Start
May 2019
Primary completion
Jun 2028
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of pilocarpine in Glaucoma and ocular hypertension (2 arms), sponsored by Montefiore Medical Center. Primary endpoint: Percentage of patients with lowering of intraocular pressure at 1 year. Started May 2019; status: recruiting.

02

Drugs

pilocarpine
03

Conditions

Glaucomaocular hypertension

Beyond the preview

Go deeper on NCT03933631.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03933631.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call